Vanda Pharmaceuticals
VNDA
VNDA
151 hedge funds and large institutions have $206M invested in Vanda Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 47 increasing their positions, 52 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 52
16% less capital invested
Capital invested by funds: $246M → $206M (-$40.3M)
Holders
151
Holding in Top 10
–
Calls
$1.57M
Puts
$261K
Top Buyers
| 1 | +$2.14M | |
| 2 | +$1.89M | |
| 3 | +$1.8M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.16M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$938K |
Top Sellers
| 1 | -$1.75M | |
| 2 | -$1.16M | |
| 3 | -$1.13M | |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$796K |
| 5 |
OAC
OMERS Administration Corp
Toronto,
Ontario, Canada
|
-$788K |